Bloomberg News

Hypermarcas Signs Agreement With Ache, EMS and Uniao Quimica

March 23, 2012

Hypermarcas SA (HYPE3) signed an agreement with Ache Laboratorios Farmaceuticos SA, EMS Participacoes SA e Uniao Quimica Farmaceutica Nacional SA to form a joint venture and create Bionovis SA, a biotechnical company that plans to invest 500 million reais in the next five years, according to a regulatory filing.

Hypermarcas will hold a 25 percent stake in the joint venture.

To contact the reporter on this story: Telma Marotto in Sao Paulo at tmarotto1@bloomberg.net

To contact the editor responsible for this story: Francisco Marcelino at mdeoliveira@bloomberg.net


The Good Business Issue
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus